University of Pittsburgh Cancer Institute (UPCI)

News

UPCI / UPMC CC Press Releases


University of Pittsburgh Cancer Institute Appoints New Director of Hematologic Malignancies Program


Pittsburgh, PA, January 10, 2011 – Clayton A. Smith, M.D., an internationally renowned hematology and oncology expert, has been named director of the Hematologic Malignancies Program at the University of Pittsburgh Cancer Institute (UPCI) and director of Leukemia and Stem Cell Transplant Clinical Services with UPMC Cancer Centers.

"We were honored when Dr. Smith agreed to join the UPCI team," said Nancy E. Davidson, M.D., director of UPCI and UPMC Cancer Centers. "Under Dr. Smith's leadership, we anticipate the Hematologic Malignancies Program, as well as our hematologic services, will play an even greater role in cancer research and cancer treatment. We are especially pleased that he will lead our efforts as part of our recently announced Mario Lemieux Foundation Center for Blood Diseases. The timing could not be better."

Before coming to UPCI, Dr. Smith served as the director of the Leukemia/Stem Cell Transplantation Program at the British Columbia Cancer Agency and as an associate professor of medicine at the University of British Columbia in Vancouver, Canada.

An accomplished cancer researcher, Dr. Smith is particularly interested in bone marrow transplantation, cancer stem cells and bioinformatics. Dr. Smith has co-authored more than 100 peer-reviewed publications. His research has been supported by grants from the National Institutes of Health, the Canadian Blood and Marrow Transplant Group, the Stem Cell Network and the Canadian Institutes of Health. He also has patented several methods regarding stem cell use.

Dr. Smith received a B.A. in biology from Rice University and his M.D. from Southwestern Medical School in Dallas. He completed his internship and residency in internal medicine at Parkland Hospital in Dallas and New York Hospital, Cornell University Medical Center, New York. After completing fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center and in bone marrow transplantation at Stanford University Medical Center, Dr. Smith served as a faculty member at Duke University and Moffitt Cancer Center.

"It's a wonderful opportunity to be able to serve one of the leading institutions in western Pennsylvania for the delivery of cancer care and the conduct of cancer research," said Dr. Smith. "UPCI and UPMC Cancer Centers both play critically important roles in the fight against cancer, and I am looking forward to working closely with Dr. Davidson and her team as we work to defeat cancer once and for all."

# # #

About the University of Pittsburgh Cancer Institute (UPCI)
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; biomedical research; compassionate patient care and support; and community-based outreach services. UPCI investigators are world-renowned for their work in clinical and basic cancer research.